Avastin vs. Lucentis: Why the Genentech Co-Pay Card Isn't Enough

Avastin vs Lucentis: Genentech Co-Pay Card Program Not Nearly Enough!

November 14, 2009

I received an e-mail this week from Genentech BioOncology, introducing their new Co-Pay Card Program. Genentech is the maker of the two drugs I have blogged about involved in the current macular degeneration treatment controversy, Lucentis and Acastin.

According to the e-mail:

“We are committed to ensuring that all eligible patients have access to the therapies they need. That is why we created the Genentech BioOncology Co-Pay Card Program, a program that gives eligible patients help with their BioOncology product co-pay.“

This program will basically pay the 20% co-pay for those patients that financially qualify. I think this is wonderful for certain treatment modalities, but not so in the case of Lucentis to treat macular degeneration. The co-pay would be around $400. What a nice gesture, what great marketing… In my opinion, this is a joke. What Genentech should be doing is seeking approval for the treatment of macular degeneration with Avastin! Then let the patient handle the $10 co-pay themselves!! Shame on you Genentech, hiding behind charity where corporate profits are the real issue!

Download Genentech Co-Pay Card Program

Back to our blog

Schedule an appointment

Please choose your preferred provider: *

Self-scheduling is not currently available for this provider, please complete form below and a member of the OCLI Vision team will contact you to schedule your appointment.

* required

First Name: *

Last Name: *

Date of birth: *

Email address: *

Cell phone number: *

Preferred location: *

Reason for appointment: *

Avastin vs Lucentis: Genentech Co-Pay Card Program Not Nearly Enough!

Services offered at OCLI

Schedule an appointment

Please choose your preferred provider: *

Please complete the following to request your appointment:

Please complete the following to request your appointment:

Please complete the following to request your appointment:

Self-scheduling is not currently available for this provider, please complete form below and a member of the OCLI Vision team will contact you to schedule your appointment.